A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol.
Quinn K, Traboni C, Penchala SD, Bouliotis G, Doyle N, Libri V, Khoo S, Ashby D, Weber J, Nicosia A, Cortese R, Pessi A, Winston A.
Quinn K, et al. Among authors: pessi a.
Sci Rep. 2017 Aug 25;7(1):9447. doi: 10.1038/s41598-017-09230-0.
Sci Rep. 2017.
PMID: 28842581
Free PMC article.
Clinical Trial.